From January 19, 2023 to March 31, 2023, the company has repurchased 445,711 shares, representing 1.97% for $0.51 million. With this, the company has completed the repurchase of 445,711 shares, representing 1.97% for $0.51 million under the buyback announced on January 19, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5126 USD | -2.34% | -12.96% | -98.11% |
May. 21 | Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M | MT |
May. 20 | Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-98.11% | 7.16M | |
+48.53% | 779B | |
+40.67% | 631B | |
-6.37% | 354B | |
+20.93% | 333B | |
+8.21% | 301B | |
+16.75% | 249B | |
-1.19% | 216B | |
+10.85% | 214B | |
+4.40% | 163B |
- Stock Market
- Equities
- SBFM Stock
- News Sunshine Biopharma, Inc.
- Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.